CLEXANE Side Effects

6613475-4 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Apathy, Blood Alkaline Phosphatase Increased, Blood Cholesterol Increased, Decreased Appetite, Dysgeusia, Gamma-glutamyltransferase Increased, Hepatotoxicity
on Feb 26, 2010 Female patient from GERMANY , 66 years of age, weighting 143.3 lb, was diagnosed with thrombosis prophylaxis, urinary tract infection (What is urinary tract infection?) and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, alanine aminotransferase increased, apathy, blood alkaline phosphatase increased, blood cholesterol increased, decreased appetite, dysgeusia, gamma-glutamyltransferase increased, hepatotoxicity. Clexane dosage: . During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ).

6608016-1 | Postoperative Wound Infection
Patient was taking Clexane (View Usage). Patient had the following side effects: postoperative wound infection on Feb 19, 2010 from JAPAN Additional patient health information: Female patient , 62 years of age, weighting 132.3 lb, . Clexane dosage: . Patient was hospitalized.

6596521-6 | Pseudomembranous Colitis
Adverse event was reported on Feb 19, 2010 by a Female patient taking Clexane (View Usage) (Dosage: ) . Location: JAPAN , 74 years of age, After Clexane was administered, patient had the following side effects: pseudomembranous colitis.

6594059-3 | Thrombosis
on Feb 18, 2010 Female patient from GERMANY , 27 years of age, was diagnosed with thrombosis and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: thrombosis. Clexane dosage: . Patient was hospitalized.


6594045-3 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Apathy, Blood Alkaline Phosphatase Increased, Blood Cholesterol Increased, Decreased Appetite, Dysgeusia, Gamma-glutamyltransferase Increased, Hepatotoxicity
on Feb 18, 2010 Female patient from GERMANY , 66 years of age, weighting 143.3 lb, was diagnosed with thrombosis prophylaxis, urinary tract infection (What is urinary tract infection?) and was treated with Clexane (View Usage). Patient had the following side effects: abdominal pain upper, alanine aminotransferase increased, apathy, blood alkaline phosphatase increased, blood cholesterol increased, decreased appetite, dysgeusia, gamma-glutamyltransferase increased, hepatotoxicity. Clexane dosage: . During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ).

6573184-7 | Myocardial Infarction, Traumatic Haematoma
Patient was taking Clexane (View Usage). After Clexane was administered, patient had the following side effects: myocardial infarction, traumatic haematoma on Feb 04, 2010 from GERMANY Additional patient health information: Male patient , 72 years of age, weighting 183.0 lb, was diagnosed with thrombosis prophylaxis and. Clexane dosage: .

6554682-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal
Adverse event was reported on Jan 25, 2010 by a Male patient taking Clexane (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 71 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6541870-0 | Spinal Haematoma
on Jan 18, 2010 Female patient from GERMANY , 70 years of age, weighting 108.0 lb, was diagnosed with thrombosis prophylaxis and was treated with Clexane (View Usage). Patient had the following side effects: spinal haematoma. Clexane dosage: .

6509918-7 | Soft Tissue Necrosis
on Dec 21, 2009 Female patient from GERMANY , 55 years of age, weighting 132.3 lb, was diagnosed with thrombosis prophylaxis and was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: soft tissue necrosis. Clexane dosage: . Patient was hospitalized.

6500513-2 | Blood Bilirubin Increased, Jaundice, Transaminases Increased
Patient was taking Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, jaundice (What is jaundice?), transaminases increased on Dec 14, 2009 from JAPAN Additional patient health information: Male patient , 55 years of age, weighting 152.1 lb, was diagnosed with thrombosis prophylaxis, gastrectomy and. Clexane dosage: . During the same period patient was treated with ASPENON (View Aspenon Review and Aspenon Label ), PENTCILLIN (View Pentcillin Review and Pentcillin Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ).

6500498-9 | Blood Bilirubin Increased, Jaundice
Adverse event was reported on Dec 14, 2009 by a Male patient taking Clexane (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis, gastrectomy and. Location: JAPAN , 64 years of age, weighting 132.3 lb, Patient had the following side effects: blood bilirubin increased, jaundice (What is jaundice?). During the same period patient was treated with PENTCILLIN (View Pentcillin Review and Pentcillin Label ), PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), ASPENON (View Aspenon Review and Aspenon Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

6497574-6 | Premature Separation Of Placenta
on Dec 11, 2009 Female patient from BRAZIL , 31 years of age, weighting 136.7 lb, was diagnosed with thrombosis prophylaxis, vitamin supplementation and was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: premature separation of placenta. Clexane dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DACTIL OB (View Dactil Ob Review and Dactil Ob Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), DIGESTIVES, INCL ENZYMES (View Digestives, Incl Enzymes Review and Digestives, Incl Enzymes Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6487260-0 | Oedema, Pemphigoid
on Dec 07, 2009 Female patient from BELGIUM , weighting 176.4 lb, was diagnosed with bronchial obstruction, hypertension, oedema and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: oedema, pemphigoid. Clexane dosage: . During the same period patient was treated with ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), BUMEX (View Bumex Review and Bumex Label ), COVERSYL /BEL/ (View Coversyl /bel/ Review and Coversyl /bel/ Label ), ACTRAPID MC (View Actrapid Mc Review and Actrapid Mc Label ), DAFLON (View Daflon Review and Daflon Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), EMCONCOR /BEL/ (View Emconcor /bel/ Review and Emconcor /bel/ Label ). Patient was hospitalized.

6483402-1 | Blood Bilirubin Increased, Jaundice, Transaminases Increased
Patient was taking Clexane (View Usage). Patient had the following side effects: blood bilirubin increased, jaundice (What is jaundice?), transaminases increased on Nov 30, 2009 from JAPAN Additional patient health information: Male patient , 55 years of age, weighting 152.1 lb, was diagnosed with thrombosis prophylaxis and. Clexane dosage: . During the same period patient was treated with PENTCILLIN (View Pentcillin Review and Pentcillin Label ).

6480403-4 | Agitation, Confusional State, Diarrhoea, Malignant Neoplasm Progression, Non-small Cell Lung Cancer, Pain, Thrombocytopenia
Adverse event was reported on Dec 01, 2009 by a Female patient taking Clexane (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: UNITED KINGDOM , weighting 154.3 lb, After Clexane was administered, patient had the following side effects: agitation, confusional state, diarrhoea, malignant neoplasm progression, non-small cell lung cancer, pain (What is pain?), thrombocytopenia. During the same period patient was treated with TARCEVA (View Tarceva Review and Tarceva Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ), CHLORHEXIDINE GLUCONATE (View Chlorhexidine Gluconate Review and Chlorhexidine Gluconate Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ).

6480055-3 | Blood Bilirubin Increased, Jaundice
on Nov 26, 2009 Male patient from JAPAN , 64 years of age, weighting 132.3 lb, was diagnosed with thrombosis prophylaxis and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, jaundice (What is jaundice?). Clexane dosage: . During the same period patient was treated with PENTCILLIN (View Pentcillin Review and Pentcillin Label ).

6477467-0 | Mixed Liver Injury, Rash Erythematous
on Nov 17, 2009 Male patient from SWITZERLAND , 94 years of age, was treated with Clexane (View Usage). Patient had the following side effects: mixed liver injury, rash erythematous. Clexane dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), PENICILLIN G (View Penicillin G Review and Penicillin G Label ), AMOXICILLIN SODIUM/CLAVULANATE POTASSIUM (View Amoxicillin Sodium/clavulanate Potassium Review and Amoxicillin Sodium/clavulanate Potassium Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), PRADIF (View Pradif Review and Pradif Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ).

6477427-X | Cardiogenic Shock, Coronary Artery Thrombosis
Patient was taking Clexane (View Usage). After Clexane was administered, patient had the following side effects: cardiogenic shock, coronary artery thrombosis on Nov 06, 2009 from SPAIN Additional patient health information: Female patient , 65 years of age, weighting 176.4 lb, was diagnosed with percutaneous coronary intervention and. Clexane dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), ATROVENT (View Atrovent Review and Atrovent Label ), UNIKET (View Uniket Review and Uniket Label ).

6476914-8 | Blood Bilirubin Increased, Jaundice
Adverse event was reported on Nov 26, 2009 by a Male patient taking Clexane (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: JAPAN , 64 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, jaundice (What is jaundice?). During the same period patient was treated with PENTCILLIN (View Pentcillin Review and Pentcillin Label ).

6473898-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal
on Dec 01, 2009 Male patient from JAPAN , 71 years of age, weighting 143.3 lb, was diagnosed with hypertension and was treated with Clexane (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Clexane dosage: . During the same period patient was treated with NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), NORVASC (View Norvasc Review and Norvasc Label ), VOLTAREN (View Voltaren Review and Voltaren Label ).

6418120-9 | Impaired Healing, Post Procedural Haemorrhage
on Oct 23, 2009 Female patient from JAPAN , 78 years of age, weighting 169.1 lb, was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: impaired healing, post procedural haemorrhage. Clexane dosage: . During the same period patient was treated with LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ). Patient was hospitalized.

6418119-2 | Impaired Healing, Post Procedural Haemorrhage
Patient was taking Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: impaired healing, post procedural haemorrhage on Oct 23, 2009 from JAPAN Additional patient health information: Female patient , 88 years of age, . Clexane dosage: . During the same period patient was treated with LOXOPROFEN SODIUM (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), MOBIC (Dose: 1 Tablet) (View Mobic Review and Mobic Label ). Patient was hospitalized.

6418118-0 | Impaired Healing, Post Procedural Haemorrhage
Adverse event was reported on Oct 23, 2009 by a Female patient taking Clexane (View Usage) (Dosage: ) . Location: JAPAN , 73 years of age, weighting 97.00 lb, Patient had the following side effects: impaired healing, post procedural haemorrhage. During the same period patient was treated with LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ). Patient was hospitalized.

6413467-4 | Cyanosis, Heart Rate Decreased, Loss Of Consciousness, Respiratory Rate Decreased
on Oct 21, 2009 Male patient from CHINA , 48 years of age, was diagnosed with acute coronary syndrome and was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: cyanosis, heart rate decreased, loss of consciousness, respiratory rate decreased. Clexane dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TRADITIONAL CHINESE MEDICINE (View Traditional Chinese Medicine Review and Traditional Chinese Medicine Label ).

6407727-0 | Abortion Induced, Foetal Cystic Hygroma, Foetal Growth Retardation
on Oct 13, 2009 Female patient from SWITZERLAND , 39 years of age, was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced, foetal cystic hygroma, foetal growth retardation. Clexane dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

6401621-7 | Heparin-induced Thrombocytopenia, Hepatic Failure
Patient was taking Clexane (View Usage). Patient had the following side effects: heparin-induced thrombocytopenia, hepatic failure on Oct 12, 2009 from SOUTH AFRICA Additional patient health information: Male patient , 60 years of age, was diagnosed with thrombosis prophylaxis, immunosuppression and. Clexane dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ACTIVASE (View Activase Review and Activase Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), PROGRAF (View Prograf Review and Prograf Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), VALCYTE (View Valcyte Review and Valcyte Label ).

6396501-X | Hepatic Enzyme Increased, Hepatocellular Injury
Adverse event was reported on Oct 01, 2009 by a Female patient taking Clexane (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), prophylaxis, hypertension and. Location: JAPAN , 33 years of age, weighting 112.4 lb, After Clexane was administered, patient had the following side effects: hepatic enzyme increased, hepatocellular injury. During the same period patient was treated with RHEUMATREX /00113801/ (View Rheumatrex /00113801/ Review and Rheumatrex /00113801/ Label ), LORCAM (View Lorcam Review and Lorcam Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), GASRICK D (View Gasrick D Review and Gasrick D Label ), FERROMIA /00023516/ (View Ferromia /00023516/ Review and Ferromia /00023516/ Label ), ALMYLAR (View Almylar Review and Almylar Label ), BLOPRESS (View Blopress Review and Blopress Label ), MUCOSTA (View Mucosta Review and Mucosta Label ).

6390621-1 | Adverse Event, Hepatic Enzyme Increased
on Aug 03, 2009 Female patient from JAPAN , 33 years of age, weighting 112.4 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), prophylaxis, hypertension and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, hepatic enzyme increased. Clexane dosage: . During the same period patient was treated with RHEUMATREX /00113801/ (View Rheumatrex /00113801/ Review and Rheumatrex /00113801/ Label ), LORCAM (View Lorcam Review and Lorcam Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), GASRICK D (View Gasrick D Review and Gasrick D Label ), FERROMIA /00023516/ (View Ferromia /00023516/ Review and Ferromia /00023516/ Label ), ALMYLAR (View Almylar Review and Almylar Label ), BLOPRESS (View Blopress Review and Blopress Label ), MUCOSTA (View Mucosta Review and Mucosta Label ).

6390618-1 | Anaemia, Injection Site Haematoma, Renal Failure Acute, Rhabdomyolysis
on Sep 30, 2009 Male patient from SPAIN , 53 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), pain (What is pain?), renal transplant, hypertension and was treated with Clexane (View Usage). Patient had the following side effects: anaemia, injection site haematoma, renal failure acute, rhabdomyolysis. Clexane dosage: . During the same period patient was treated with NOLOTIL /00473101/ (View Nolotil /00473101/ Review and Nolotil /00473101/ Label ), PREDNISONE NOS (View Prednisone Nos Review and Prednisone Nos Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ADALAT (View Adalat Review and Adalat Label ), CARDURA (View Cardura Review and Cardura Label ), CELLCEP (View Cellcep Review and Cellcep Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ). Patient was hospitalized.

6380391-5 | Hepatic Function Abnormal
Patient was taking Clexane (View Usage). After Clexane was administered, patient had the following side effects: hepatic function abnormal on Sep 24, 2009 from JAPAN Additional patient health information: Female patient , 85 years of age, weighting 135.1 lb, was diagnosed with hypertension and. Clexane dosage: . During the same period patient was treated with DIOVANE (View Diovane Review and Diovane Label ), LIVALO (View Livalo Review and Livalo Label ), SEVEN EP (View Seven Ep Review and Seven Ep Label ), DRAMAMINE /00019501/ (View Dramamine /00019501/ Review and Dramamine /00019501/ Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

6361288-3 | Coagulopathy, Haematoma, Haemoglobin Decreased, International Normalised Ratio Increased
Adverse event was reported on Sep 14, 2009 by a Female patient taking Clexane (View Usage) (Dosage: ) . Location: GERMANY , 91 years of age, weighting 178.6 lb, Patient experienced the following unwanted or unexpected effects: coagulopathy, haematoma, haemoglobin decreased, international normalised ratio increased. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), COTRIMOXAZOL AL (Dose: 2x1 Df) (View Cotrimoxazol Al Review and Cotrimoxazol Al Label ), MARCUMAR (Dose: Not Reported) (View Marcumar Review and Marcumar Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DIGESTIVES, INCL ENZYMES (Dose: 3x2 Df) (View Digestives, Incl Enzymes Review and Digestives, Incl Enzymes Label ), CLONT /00012501/ (View Clont /00012501/ Review and Clont /00012501/ Label ).

6356404-3 | Hypotension
on Sep 09, 2009 Female patient from GERMANY , 80 years of age, was treated with Clexane (View Usage). Patient had the following side effects: hypotension. Clexane dosage: .

6356401-8 | Incorrect Dose Administered, Myocardial Infarction
on Sep 11, 2009 Male patient from RUSSIAN FEDERATION , 53 years of age, was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: incorrect dose administered, myocardial infarction. Clexane dosage: .

6339204-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bilirubin Conjugated Increased, Blood Bilirubin Unconjugated Increased, Hepatic Function Abnormal, Hyperbilirubinaemia, Liver Injury
Patient was taking Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin unconjugated increased, hepatic function abnormal, hyperbilirubinaemia, liver injury on Aug 27, 2009 from JAPAN Additional patient health information: Male patient , 71 years of age, weighting 131.4 lb, was diagnosed with thrombosis prophylaxis and. Clexane dosage: . During the same period patient was treated with MICARDIS (Dose: 1 Tablet) (View Micardis Review and Micardis Label ), FERRUM (Dose: 1 Capsule) (View Ferrum Review and Ferrum Label ), FLOMOX (Dose: 3 Tablets) (View Flomox Review and Flomox Label ). Patient was hospitalized.

6337638-0 | Contusion, Hypertension, Immediate Post-injection Reaction, Injection Site Pain, Tremor
Adverse event was reported on Aug 27, 2009 by a Male patient taking Clexane (View Usage) (Dosage: ) was diagnosed with pulmonary embolism (What is pulmonary embolism?), prophylaxis and. Location: CANADA , 65 years of age, Patient had the following side effects: contusion, hypertension, immediate post-injection reaction, injection site pain, tremor. During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ), MAVIK (View Mavik Review and Mavik Label ), PLAVIX (View Plavix Review and Plavix Label ), PARIET (View Pariet Review and Pariet Label ), DIAMICRON (View Diamicron Review and Diamicron Label ).

6334870-7 | Antepartum Haemorrhage, Premature Separation Of Placenta
on Aug 19, 2009 Female patient from BRAZIL , 33 years of age, weighting 119.0 lb, was diagnosed with systemic lupus erythematosus and was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: antepartum haemorrhage, premature separation of placenta. Clexane dosage: .

6323077-5 | Contusion, Hypertension, Immediate Post-injection Reaction, Injection Site Pain, Tremor
on Aug 17, 2009 Male patient from CANADA , 65 years of age, was diagnosed with pulmonary embolism (What is pulmonary embolism?), prophylaxis and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: contusion, hypertension, immediate post-injection reaction, injection site pain, tremor. Clexane dosage: . During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ), MAVIK (View Mavik Review and Mavik Label ), PLAVIX (View Plavix Review and Plavix Label ), PARIET (View Pariet Review and Pariet Label ), DIAMICRON (View Diamicron Review and Diamicron Label ).

6316274-6 | Hypotension
Patient was taking Clexane (View Usage). Patient had the following side effects: hypotension on Aug 10, 2009 from GERMANY Additional patient health information: Female patient , 80 years of age, . Clexane dosage: .

6316273-4 |
Adverse event was reported on Aug 14, 2009 by a Male patient taking Clexane (View Usage) (Dosage: ) . Location: KOREA, REPUBLIC OF , 72 years of age, weighting 147.7 lb, . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ).

6315406-3 | Chest Pain, Convulsion
on Aug 14, 2009 Male patient from KOREA, REPUBLIC OF , 72 years of age, weighting 147.7 lb, was diagnosed with stent placement and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), convulsion. Clexane dosage: 60 Mg/0.6 Ml Every 12 Hours. During the same period patient was treated with PLAVIX (Unk) (View Plavix Review and Plavix Label ).

6305222-0 | Hepatic Function Abnormal
on Aug 05, 2009 Female patient from JAPAN , 49 years of age, weighting 123.5 lb, was diagnosed with infection prophylaxis and was treated with Clexane (View Usage). Patient had the following side effects: hepatic function abnormal. Clexane dosage: . During the same period patient was treated with FERROMIA /00023516/ (View Ferromia /00023516/ Review and Ferromia /00023516/ Label ), CEFMETAZON (View Cefmetazon Review and Cefmetazon Label ). Patient was hospitalized.

6305221-9 | Hepatic Function Abnormal
Patient was taking Clexane (View Usage). After Clexane was administered, patient had the following side effects: hepatic function abnormal on Aug 04, 2009 from JAPAN Additional patient health information: Female patient , 85 years of age, weighting 135.1 lb, was diagnosed with hypertension and. Clexane dosage: . During the same period patient was treated with DIOVANE (View Diovane Review and Diovane Label ), LIVALO (View Livalo Review and Livalo Label ), SEVEN EP (View Seven Ep Review and Seven Ep Label ), DRAMAMINE /00019501/ (View Dramamine /00019501/ Review and Dramamine /00019501/ Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

6305220-7 | Impaired Healing, Post Procedural Haemorrhage
Adverse event was reported on Aug 03, 2009 by a Female patient taking Clexane (View Usage) (Dosage: ) . Location: JAPAN , 73 years of age, weighting 97.00 lb, Patient experienced the following unwanted or unexpected effects: impaired healing, post procedural haemorrhage. During the same period patient was treated with LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ). Patient was hospitalized.

6305218-9 | Impaired Healing, Post Procedural Haemorrhage
on Jul 31, 2009 Female patient from JAPAN , 79 years of age, weighting 117.1 lb, was treated with Clexane (View Usage). Patient had the following side effects: impaired healing, post procedural haemorrhage. Clexane dosage: . During the same period patient was treated with FARESTON /00828101/ (View Fareston /00828101/ Review and Fareston /00828101/ Label ). Patient was hospitalized.

6302534-1 | Anaemia, Haematocrit Decreased, Haemoglobin Decreased, Haemorrhage, Red Blood Cell Count Decreased
on Aug 04, 2009 Female patient from JAPAN , 87 years of age, weighting 77.16 lb, was diagnosed with hip surgery, angina pectoris and was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: anaemia, haematocrit decreased, haemoglobin decreased, haemorrhage, red blood cell count decreased. Clexane dosage: . During the same period patient was treated with OMEPRAL (View Omepral Review and Omepral Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), PRIMPERAN /00041901/ (View Primperan /00041901/ Review and Primperan /00041901/ Label ), CEROCRAL (View Cerocral Review and Cerocral Label ), SIGMART (View Sigmart Review and Sigmart Label ), FOIPAN (View Foipan Review and Foipan Label ), EXCELASE (View Excelase Review and Excelase Label ).

6299416-0 | Liver Function Test Abnormal
Patient was taking Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal on Jul 31, 2009 from CZECH REPUBLIC Additional patient health information: Male patient , 26 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), pain (What is pain?) and. Clexane dosage: . During the same period patient was treated with WARFARIN (Dose: Unk) (View Warfarin Review and Warfarin Label ), COXTRAL (View Coxtral Review and Coxtral Label ), GLYVENOL (View Glyvenol Review and Glyvenol Label ), FLAVOBION (View Flavobion Review and Flavobion Label ), NOVALGIN /00039501/ (View Novalgin /00039501/ Review and Novalgin /00039501/ Label ), ZINNAT (View Zinnat Review and Zinnat Label ), PARALEN (View Paralen Review and Paralen Label ). Patient was hospitalized.

6209988-X | Contusion, Injection Site Haematoma, Vascular Pseudoaneurysm
Adverse event was reported on May 27, 2009 by a Female patient taking Clexane (View Usage) (Dosage: ) was diagnosed with coronary artery disease (What is coronary artery disease?) and. Location: INDIA , 65 years of age, weighting 154.3 lb, Patient had the following side effects: contusion, injection site haematoma, vascular pseudoaneurysm. During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

6208477-6 | Haemolytic Anaemia
on May 20, 2009 Female patient from TURKEY , 26 years of age, was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: haemolytic anaemia. Clexane dosage: . During the same period patient was treated with BECOZYME C (View Becozyme-c Review and Becozyme-c Label ), FOLBIOL (View Folbiol Review and Folbiol Label ), BABYPRIN (View Babyprin Review and Babyprin Label ). Patient was hospitalized.

6208476-4 | Haemolytic Anaemia
on May 20, 2009 Female patient from TURKEY , 30 years of age, was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia. Clexane dosage: . During the same period patient was treated with BECOZYME C (View Becozyme-c Review and Becozyme-c Label ), FOLBIOL (View Folbiol Review and Folbiol Label ), BABYPRIN (View Babyprin Review and Babyprin Label ). Patient was hospitalized.

6208475-2 | Haemolytic Anaemia
Patient was taking Clexane (View Usage). Patient had the following side effects: haemolytic anaemia on May 20, 2009 from TURKEY Additional patient health information: Female patient , 32 years of age, . Clexane dosage: . During the same period patient was treated with BECOZYME C (View Becozyme-c Review and Becozyme-c Label ), FOLBIOL (View Folbiol Review and Folbiol Label ), BABYPRIN (View Babyprin Review and Babyprin Label ). Patient was hospitalized.